#clinical trial — Thursday, February 05, 2026 (3 items)
| 0 | ℹ |
Improved Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer.
(nejm.org)
|
New England Journal of Medicine 2026-02-05 | #clinical trial #survival #recurrence #prostate cancer #androgen receptor | |
| 0 | ℹ |
Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer.
(nejm.org)
|
New England Journal of Medicine 2026-02-05 | #clinical trial #immunotherapy #breast cancer #her2 #metastatic | |
| 0 | ℹ |
A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide.
(nejm.org)
|
New England Journal of Medicine 2026-02-05 | #clinical trial #cardiovascular #cholesterol #drug therapy |